Coiante Scott M has filed 8 insider transactions across 1 company since January 2025.
Most recent transaction: a option exercise of 160237 shares of LEXICON PHARMACEUTICALS, INC. ($LXRX) on February 28, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 28, 2026 | LEXICON PHARMACEUTICALS, INC. | $LXRX | Coiante Scott M | SVP, Chief Financial Officer | M | Restricted Stock Units | 160237 | $0.00 | 320,473.0000 | 365,780,799 | 33.33% | 0.04% |
| Feb. 28, 2026 | LEXICON PHARMACEUTICALS, INC. | $LXRX | Coiante Scott M | SVP, Chief Financial Officer | M | Common Stock | 160237 | $0.00 | 160,237.0000 | 365,780,799 | 9999.99% | 0.04% |
| Feb. 28, 2026 | LEXICON PHARMACEUTICALS, INC. | $LXRX | Coiante Scott M | SVP, Chief Financial Officer | F | Common Stock | 54881 | $1.47 | 105,356.0000 | 365,780,799 | 34.25% | 0.02% |
| Feb. 12, 2026 | LEXICON PHARMACEUTICALS, INC. | $LXRX | Coiante Scott M | SVP, Chief Financial Officer | A | Stock Option (Right to Buy) | 409020 | $0.00 | 409,020.0000 | 365,780,799 | 9999.99% | 0.11% |
| Feb. 12, 2026 | LEXICON PHARMACEUTICALS, INC. | $LXRX | Coiante Scott M | SVP, Chief Financial Officer | A | Restricted Stock Units | 272680 | $0.00 | 272,680.0000 | 365,780,799 | 9999.99% | 0.07% |
| Feb. 13, 2025 | LEXICON PHARMACEUTICALS, INC. | $LXRX | Coiante Scott M | SVP, Chief Financial Officer | A | Stock Option (Right to Buy) | 721070 | $0.00 | 721,070.0000 | 363,020,303 | 9999.99% | 0.20% |
| Feb. 13, 2025 | LEXICON PHARMACEUTICALS, INC. | $LXRX | Coiante Scott M | SVP, Chief Financial Officer | A | Restricted Stock Units | 480710 | $0.00 | 480,710.0000 | 363,020,303 | 9999.99% | 0.13% |
| Jan. 2, 2025 | LEXICON PHARMACEUTICALS, INC. | $LXRX | Coiante Scott M | SVP, Chief Financial Officer | A | Stock Option (Right to Buy) | 230000 | $0.00 | 230,000.0000 | 363,020,303 | 9999.99% | 0.06% |